Cumulative increase of 0.52 percent expected in breast cancer deaths by 2030 due to disruptions during the first six months of the pandemic
Women’s Cancer Screenings Plummeted During Pandemic
Decline especially noticeable among women of racial and ethnic minority groups with low incomes
Testing for STIs in the U.S. Dropped During Early Pandemic
Low point in testing for chlamydia and gonorrhea seen in early April 2020, raising the possibility of many missed cases
ATS Guideline Addresses Testing for Viral Pathogens in CAP
Nucleic acid-based testing for noninfluenza pathogens suggested for hospitalized patients who have severe CAP or are immunocompromised
Hepatitis C Testing, Treatment Down During the Pandemic
Authors urge identifying people who have delayed or skipped health care services
COVID-19-Associated Cancer Screening Deficit Quantified in U.S.
Absolute deficit in screening estimated at 3.9, 3.8, and 1.6 million for breast, colorectal, and prostate cancers, respectively
Rapid Antigen Test Can ID Contagious People in SARS-CoV-2 Outbreak
Percentage positive agreement was 95 percent for BinaxNOW with virus culture for ID of replication-competent virus
Recovered but RT-PCR-Positive Individuals Unlikely to Transmit SARS-CoV-2
Those who have clinically recovered but continue to test positive on RT-PCR after the requisite isolation seem not to be infectious to others
‘Vaccine Passports’ to Be Part of Britain’s Reopening Plan
Other proposals in the plan expected to be unveiled Monday include frequent mass testing with at-home test kits
More Advanced Cancer at Presentation Possible Effect of Pandemic
May be the result of treatment postponements and deferrals that were common at the beginning of the pandemic